1,586
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Physicochemical characterization of atorvastatin calcium/ezetimibe amorphous nano-solid dispersions prepared by electrospraying method

, , , &
Pages 1138-1145 | Received 23 Apr 2016, Accepted 12 Jun 2016, Published online: 13 Jul 2016

Figures & data

Figure 1. SEM images of (І) ATV/PVP, (ІІ) EZT/PVP and (ІІІ) ATV/EZT:PVP nano-solid dispersions, (A) and (B) ESs with the drug to polymer ratio of 1:1 and solution concentrations of 10% and 20% (w/v), respectively, (C) and (D) ESs with the drug to polymer ratio of 1:5 and solution concentrations of 10% and 20% (w/v), respectively.

Figure 1. SEM images of (І) ATV/PVP, (ІІ) EZT/PVP and (ІІІ) ATV/EZT:PVP nano-solid dispersions, (A) and (B) ESs with the drug to polymer ratio of 1:1 and solution concentrations of 10% and 20% (w/v), respectively, (C) and (D) ESs with the drug to polymer ratio of 1:5 and solution concentrations of 10% and 20% (w/v), respectively.

Figure 2. DSC thermograms of the PVP K30, pure drugs, corresponding physical mixtures (PMs), and electrosprayed samples (ESs) all in 1:1 ratio.

Figure 2. DSC thermograms of the PVP K30, pure drugs, corresponding physical mixtures (PMs), and electrosprayed samples (ESs) all in 1:1 ratio.

Figure 3. PXRD patterns of the PVP K30, pure drugs, corresponding physical mixtures (PMs), and electrosprayed samples (ESs) all in 1:1 ratio.

Figure 3. PXRD patterns of the PVP K30, pure drugs, corresponding physical mixtures (PMs), and electrosprayed samples (ESs) all in 1:1 ratio.

Figure 4. FTIR spectra of the PVP K30, pure drugs, corresponding physical mixtures (PMs), and electrosprayed samples (ESs) all in 1:1 ratio.

Figure 4. FTIR spectra of the PVP K30, pure drugs, corresponding physical mixtures (PMs), and electrosprayed samples (ESs) all in 1:1 ratio.

Figure 5. Drug release profile of various formulations. Left panel (A) ATV release from ATV/EZT binary mixture (BM—○—), pure drug (—•—), physical mixtures (PM—▵— —□—), and electrosprayed samples (ES—▴— —▪—) all in 1:1 ratio. Right panel (B) EZT release from BM, pure drug, PMs, and ESs as mentioned above. Each point represents mean ± SD (n = 3).

Figure 5. Drug release profile of various formulations. Left panel (A) ATV release from ATV/EZT binary mixture (BM—○—), pure drug (—•—), physical mixtures (PM—▵— —□—), and electrosprayed samples (ES—▴— —▪—) all in 1:1 ratio. Right panel (B) EZT release from BM, pure drug, PMs, and ESs as mentioned above. Each point represents mean ± SD (n = 3).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.